HomeHEALTH/MEDICINE/MINDCANCER TREATMENTS

Blue vs Green: Why one of breast cancer surgery’s biggest advances is simply changing the colour of the dye

When people think about breakthroughs in breast cancer treatment, they often picture cutting-edge robots, artificial intelligence or revolutionary new medicines. However, according to Associate Professor...

Common First Reactions After a Cancer Diagnosis (And Why There’s No “Right” Way to Feel)

Receiving a cancer diagnosis can feel like the ground has shifted beneath you. One moment you’re living your everyday life; the next, everything feels...

Five simple signs that could save your life

This World Blood Cancer Day (28 May), the Leukaemia Foundation is issuing an urgent national call: know the signs of blood cancer and act...

Barber to the stars Frank Ciccone is making a buzz for Australians living with blood cancer

  Leukaemia Foundation / World's Greatest Shave World's Greatest Shave Hair Ambassador, Frank Ciccone:  available for interview on request.  Please contact the Leukaemia Foundation media team...

Nature may provide the key to beating drug resistant melanoma

Antimicrobial peptides derived from a crab and a spider may provide the pathway to overcoming drug resistance in advanced melanoma. QUT researchers based at Brisbane's...

We need to talk about metastatic breast cancer – BCNA’s new media guide

Breast Cancer Network Australia Breast Cancer Network Australia (BCNA) – Australia’s leading voice for people affected by breast cancer – has released a media guide...

Angie and Dom set to overhaul their hair for Australians living with blood cancer

  Leukaemia Foundation / World's Greatest Shave Well-known Aussies Angie Kent and Domenica Calarco (Dom) are set to undergo a massive hair transformation as the Leukaemia...

AI helps ID cancer risk factors

A novel study from the University of South Australia has identified a range of metabolic biomarkers that could help predict the risk of cancer. Deploying...

First-line treatment option available for eligible Australians with a type of aggressive breast cancer

An estimated 1,500 eligible Australians with triple-negative breast cancer (TNBC) could receive access to immuno-oncology therapy KEYTRUDA (pembrolizumab) as a first-line treatment option.1,2 KEYTRUDA is...

Anti-rejection medication and immunotherapy kicks cancer and protects kidney transplants

Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant patients with incurable cancer, as new research shows it...
- Advertisement -[the_ad_group id="28689"]

LATEST ARTICLES